Review articlePublished 11 Oct 2021
Review of the Pathological Mechanism and Development of Treatments for Retinitis Pigmentosa with Mer Tyrosine Kinase Mutations Using Patient-Derived Induced Pluripotent Stem Cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Retinitis Pigmentosa (RP) is an incurable disease for which effective treatments are lacking. Mer tyrosine kinase (MERTK) is a causative gene of RP. Royal College of Surgeons rats with a Mertk mutation showed impaired phagocytosis of the photoreceptor outer segment by the Retinal pigment Epithelium (RPE). Using RPE differentiated from induced Pluripotent Stem Cells (iPSC-RPE) of RP patients carrying MERTK mutations, recent studies have shown deterioration of phagocytosis in the iPSC-RPE. This review focused on the function of phagocytosis of iPSC-RPE cells derived from RP patients carrying MERTK mutations and discussed the possibility of developing treatments for this disease using this in vitro disease model.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Research
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Miho Tagawa”
- BylineArticles whose byline prints “Hanako Ohashi Ikeda”
- BylineArticles whose byline prints “Masayuki Hata”
- BylineArticles whose byline prints “Yumi Inoue”
- BylineArticles whose byline prints “Akitaka Tsujikawa”
